Journal of Diabetes Investigation

Article	Citations
	137
LGR signaling and metabolic regulation: A new frontier in addressing insulin resistance and diabetes treatment	92
Issue Information	63
	51
Graft failure after allogeneic islet transplantation in a patient with type 1 diabetes and a high anti‐glutamic acid decarboxylase antibody titer	51
	51
Relationship between diabetes treatment status and occupational accidents	50
Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24–28 gestational weeks	43
Continuous glucose monitoring reveals bimodal glycemic patterns during and outside Capivasertib administration	39
Association between low‐carbohydrate diets and continuous glucose monitoring‐derived time in ranges	37
Dual‐center prospective validation of an early second‐trimester predictive model integrating BMI trajectories and pathophysiological biomarkers for g	37
Safety and effectiveness of dulaglutide 0.75 mg in Japanese patients with type 2 diabetes in real‐world clinical practice: 36 month post‐marketing observational study	34
Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity in patients with type 2 diabetes	33
Comment on “The association between COVID ‐19 and incident gestational diabetes: A population‐based case–control study of the National Health Insuran	32
Effects of high‐intensity interval walking training on muscle strength, walking ability, and health‐related quality of life in people with diabetes accompanied by lower extremity weakness: A randomize	32
Impact of the COVID‐19 pandemic on the glycemic control in people with diabetes mellitus: A retrospective cohort study	28
Molecular mechanism for platelet hyperreactivity in diabetes mellitus	28
Association between equol producers and type 2 diabetes mellitus among Japanese older adults	28
High‐density lipoprotein in diabetes: Structural and functional relevance	26
Uhrf1 downregulation promotes β‐cell dedifferentiation by decreasing Foxo1 expression in type 2 diabetes	26
Incretin hormones: Revolutionizing the treatment landscape for kidney and liver diseases in type 2 diabetes and obesity	25
Leaving no stone unturned from bench to bedside: Challenges and future perspectives in diabetic polyneuropathy	24
Tracing the molecular landscape of diabetic nephropathy: Insights from machine learning and experiment verification	24
Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM‐Japan study	24
Trends in incidence rates of childhood type 1 diabetes mellitus: A retrospective study in Isfahan province, Iran	23

Association of cardiovascular health metrics with annual incidence of prediabetes or diabetes: Analysis of a nationwide real‐world database	23
Is a low‐carbohydrate, high‐fat diet feasible for people with type 2 diabetes and nonalcoholic fatty liver disease?	23
Influence of disease course and comprehensive management on blood glucose level in children and adolescents with type 2 diabetes mellitus	22
Cordycepin nephroprotection: From STZ mouse to human T2D	21
An update of contemporary insulin therapy	21
Glycemic metrics in Japanese isCGM users – Analysis by diabetes type and therapy	21
Commentary on “Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prosp	21
LX9211, a rising star for relieving of diabetic peripheral neuropathic pain	20
Letter to the Editor in Response to “Association between severity of diabetic complications and risk of cancer in middle‐aged patients with type 2 diabetes”	20
Resistin G–A haplotype at SNP‐420/‐358 is associated with the latent sarcopenic obesity index in the toon genome study	20
Letter to the Editor in response to the article “Effect of luseogliflozin on liver fibrosis differs depending on alcohol consumption in patients with type 2 diabetes”	20
Differences in cause of death and age at death between people with and without diabetes over 10 years (2010–2020): A cross‐sectional study in Japan	19
Fulminant type 1 diabetes with high‐titer anti‐glutamic acid decarboxylase antibodies: Likely rapid progression from stage 2 to 3	19
Two decades of diabetes prevention: Sustained benefits, heterogeneous effects, and implications for precision prevention	19
The causal relationship between gestational diabetes mellitus and postpartum depression: A Mendelian randomization study	19
The relationship between serum adipokine fibroblast growth factor‐21 and gestational diabetes mellitus	19
Diabetes care in China: Innovations and implications	19
Fermented soybean foods and diabetes	18
Precision medicine in diabetes prediction: Exploring a subgroup‐specific biomarker strategy for risk stratification	18
Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English version)	18
Construction of a metabolic‐immune model for predicting the risk of diabetic nephropathy and study of gut microbiota	17
Letter to the Editor in response to “Association between thyroid dysfunction and cognitive impairment in type 2 Diabetes Mellitus: A cross‐sectional study”	17
Long‐term efficacy of encapsulated xenogeneic islet transplantation: Impact of encapsulation techniques and donor genetic traits	17
Gastric filling ultrasound in assessing gastrointestinal motility in type 2 diabetic patients with neuropathy: A clinical study	17
Urinary extracellular vesicle miRNA signature reflects pancreatic islet stress in type 2 diabetes	16
Stimulatory effect of imeglimin on incretin secretion	16
Efficacy, safety and tolerability of imeglimin in patients with type 2 diabetes mellitus: A meta‐analysis of randomized controlled trials	16
Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes	16
Diabetes mellitus impacts on expression of DNA mismatch repair protein PMS2 and tumor microenvironment in pancreatic ductal adenocarcinoma	15
Construction of a prognostic assessment model for diabetic nephropathy based on serum fibrinogen and renal tissue IFTA score	15
Machine learning for the prediction of atherosclerotic cardiovascular disease during 3‐year follow up in Chinese type 2 diabetes mellitus patients	15
	15
	15
MiR‐488‐3p facilitates wound healing through CYP1B1‐mediated Wnt/β‐catenin signaling pathway by targeting MeCP2	15
Genetic variant profiling of neonatal diabetes mellitus in Iranian patients: Unveiling 58 distinct variants in 14 genes	15
Study of insulin infusion in diabetic rats with an ultra‐low‐cost insulin pump for managing blood glucose levels	14
Issue Information	14
Issue Information	14
Effect of sodium–glucose cotransporter 2 inhibitor medication on new prescriptions of antihypertensives, antigout/antihyperuricemics and antidyslipidemics in Japan: Analysis using the JMDC	14
Retrospective analysis of influences of sacubitril/valsartan in patients with diabetes with poorly controlled blood pressure in Japan	14
Effectiveness and safety of sodium–glucose cotransporter 2 inhibitors in Asian populations	14
Validation using item response theory, and assessment of sensitivity to change of the Hypoglycemia Awareness Questionnaire in patients with type 2 diabetes treated with insulin	13
Role of the UHRF1 – KLHL6 – CORO2B axis in obes	13
Comment on “A machine learning approach to predicting severe diabetes distress in adults with type 1 diabetes mellitus”	13
A review of capillary β‐hydroxybutyrate cut‐off levels for the exclusion and identification of diabetic ketoacidosis	13
Comparative effects of fixed‐dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled	13
Impact of COVID‐19 pandemic on behavioral changes and glycemic control and a survey of telemedicine in patients with diabetes: A multicenter retrospective observational study	13
Associations of age‐adjusted coefficient of variation of R‐R intervals with autonomic and peripheral nerve function in non‐elderly persons with diabetes	13
Toward a cure for diabetes: iPSC and ESC‐derived islet cell transplantation trials	13
Letter to the Editor in response to the article “Associations between peripheral blood mitochondrial genomic variants and gestational diabetes mellitus and postpartum abnormal glucose metabolism”	13

Bridging the gap: Strengthening shared care for diabetes in Japan	13
Deterioration in ankle reflex is associated with a reduced estimated glomerular filtration rate in patients with type 2 diabetes: A retrospective observational cohort study	13
Trends in prescribing sodium‐glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular‐renal disease in South Korea, 2015–2021	13
Taiwanese consensus statement on the use of diabetes‐specific formula: Scientific evidence	12
Awareness of the risk factors and interventions for dementia among outpatients with diabetes	12
Improvement of hepatic steatosis and fibrosis in diabetes: Which bariatric procedure is more appropriate?	12
Factors associated with bleeding complications in patients with coronavirus disease 2019 admitted to intensive care units: A multicenter retrospective cohort study	12
miR‐130a‐3p enhances autophagy through the YY1/PI3K/AKT/mTOR signaling pathway to regulate macrophage polarization and alleviate diabetic retinop	12
Continuous glucose monitoring–guided management of capivasertib‐associated hyperglycemia: A case series of three patients	12
Circulating selenoprotein P levels predict glucose‐lowering and insulinotropic effects of metformin, but not alogliptin: A post‐hoc analysis	12
Accelerating innovation and ensuring the thoughtful withdrawal of lifeline medicines for people living with diabetes in Asia	12
Letter to the Editor in Response to ‘A prediction model for diabetes complications using the Kokuho Database and its application to public health services in Japan’	12
Epigenetic regulation of core genes linking to diabetic nephropathy progression: Lesson from FinnDiane type 1 diabetes study	12
Classification of Japanese type 1 diabetes based on clinical phenotypes and its association with diabetic complications: Across‐sectional study	12
LncRNA TCF7 contributes to high glucose‐induced damage in human podocytes by up‐regulating SEMA3Avia sponging miR‐16‐5p	11
Multiple positive points during the 75 g oral glucose tolerance test are good predictors for early insulin therapy in gestational diabetes mellitus diagnosed before 24 gestational weeks	11
Erratum	11
Sleep duration and food intake in people with type 2 diabetes mellitus and factors affecting confectionery intake	11
Role of glycosylphosphatidylinositol‐anchored high‐density lipoprotein binding protein 1 in hypertriglyceridemia and diabetes	11
Characterization of the visually impaired patients with diabetes mellitus in Japan	11
Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point‐of‐care device for nerve conduction studies	11
miR‐92a aggravates metabolic syndrome via KLF2/miR‐483 axis	11
Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals	11
Letter to the Editor in Response to “A novel index for diagnosis of type 2 diabetes mellitus: Cholesterol, high density lipoprotein, and glucose ( CHG	11
Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: Insights from the TLGS	11
Incidence of treatment intensification based on HbA1c trends in people with type 2 diabetes	11
Comparing the clinical significance and antigen specificity of insulinoma‐associated antigen‐2 autoantibodies between radioimmunoassay and enzyme‐linked immunosorbent assay in Japanese pati	11
Effects of hybrid closed‐loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor‐augmented pump: A prospective single‐center observational study	10
Extracellular vesicles from adipose‐derived mesenchymal stem cells prevent high glucose‐induced retinal ganglion cell pyroptosis through a microRNA‐26a‐5p‐dependent mechanism	10
Genetic basis of Asian diabetes	10
	10
Effect of luseogliflozin on liver fibrosis differs depending on alcohol consumption in patients with type 2 diabetes	10
Neurodevelopmental delay up to the age of 4 years in infants born to women with gestational diabetes mellitus: The Japan Environment and Children's Study	10
The association between alcohol drinking and glycemic management among people with type 2 diabetes in China	10
Sodium zirconium cyclosilicate compared with potassium restriction for hyperkalemia management in type 2 diabetes: The SILVERSTAR trial	10
NAA10 and BTRC drive CREBRF degradation in endoplasmic reticulum st	10
Issue Information	10
Lipid signature changes of women with gestational diabetes mellitus in response to puerperal exclusive breastfeeding	10
Sudomotor dysfunction in people with type 1 diabetes with and without clinical peripheral neuropathy: A study from Pune, India	10
Dapagliflozin does not impair microvascular hemorheology in type 2 diabetes mellitus: A multicenter randomized controlled trial (D‐ PATH study)	10
The era of continuous glucose monitoring and its expanded role in type 2 diabetes	10
Contribution of animal models to diabetes research: Its history, significance, and translation to humans	10
Body mass index and peripheral neuropathy across the glucose tolerance spectrum in Japanese adults	10
Effectiveness of the presence of diabetologists for perioperative complications in patients with diabetes undergoing colorectal cancer surgery: A nationwide inpatient database in Japan	10
Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: A randomized controlled trial	10
Machine learning‐based risk prediction model for neuropathic foot ulcers in patients with diabetic peripheral neuropathy	9
Clinical characteristics of Sarcopenic obesity in Japanese people with type 2 diabetes: A post hoc analysis of the sub‐cohort iD	9
Carotid atherosclerosis: An independent risk factor for small fiber nerve dysfunction in patients with type 2 diabetes mellitus	9
Effect of patient characteristics on the efficacy and safety of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus: A post‐hoc analysis of two randomized, placebo	9
Commentary on glucose reduction in type 2 diabetes (GRADE)	9
Methodological concerns on the predictive performance evaluation of anthropometric indices	9
Effects of nutrient metabolism on pancreatic β‐cell mass and function: Recent findings	9
Response to Commentary on ‘Diminished levels of insulin‐like growth factor‐1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients’	9
Recent updates to understand the heterogeneity of type 2 diabetes mellitus	9
Adipocyte exosome miR‐4472 inhibits glucose uptake in skeletal muscle through downregulation of MEF2D	9
Immediate effect of textured insoles on the balance in patients with diabetic neuropathy	9
Efficacy of MiniMed ™ 780G ® on glucose management, sleep quality, and psychological aspects in pe	9
PLAGL1 overexpression exacerbates type 1 diabetes by inducing β‐cell apoptosis via oxidative stress‐dependent dual DNA	9
Insulin allergy manifesting soon after COVID‐19 vaccination (BNT162b2)	9
Cardiovascular and kidney benefits of GLP ‐1 receptor agonists across large randomized placebo‐controlled trials	9
Immunoglobulin heavy constant gamma 1 silencing decreases tonicity‐responsive enhancer‐binding protein expression to alleviate diabetic nephropathy	9
Improving diagnostic accuracy of 3 Screen ICA ELISA kit in the identification of Japanese type 1 diabetes	9
Characteristics of subjects with type 2 diabetes enrolled in randomized controlled trials and non‐randomized controlled trials in Japan: A systematic review	9
Serum metabolomics signature of maternally inherited diabetes and deafness by gas chromatography–time of flight mass spectrometry	9
Relationship between nerve ultrasonography image and electrophysiology in diabetic polyneuropathy	9
Clinical value of high‐frequency ultrasound and serum miR‐92a‐3p in diabetic peripheral neuropathy	9
Comment on a recent article titled ‘Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia’	9
Changes of HbA1c variability after the switch to a longer‐acting insulin analog in people with type 1 diabetes	9
Paroxysmal sympathetic hyperactivity secondary to hypoglycemic encephalopathy: A case report	9
Electrophysiological diagnosis using the coefficient of variation of R‐R intervals and a point‐of‐care nerve conduction device is highly correlated to the diagnosis of diabetic polyneuropathy using co	9
Targeting PI3K/AKT and MEK/ERK pathways for synergic effects on improving features of peripheral diabetic neuropathy	9
Association of glucagon‐like peptide‐1 receptor agonist use with clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes	8
Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate	8
High HOMA2‐B: A novel risk factor for diabetic peripheral neuropathy beyond metabolic syndrome components in type 2 diabetes	8
Comment on ‘Glycemic control and renal function decline in patients with chronic coronary syndrome: A multicenter cohort study’	8
Construction and validation of nomogram prediction model for ketoacidosis in elderly diabetic patients based on baseline data and glycolipid metabolism	8
Issue Information	8
Factors associated with discrepancy between glycated hemoglobin and glucose management indicator	8
Neonatal diabetes mellitus around the world: Update 2024	8
Low‐carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials	8

YY2 mediates transcriptional repression of PHGDH and expedites oxidative stress in retinal pigment epithelial cells in diabetic retinopathy	8
Betagenin: New intestine‐derived hormone which ameliorates diabetes	8
Protein consumption during pregnancy and risk of gestational diabetes mellitus: Insights from a multi‐center case–control study	8
Type 1 diabetes‐specific distress among adults with type 1 diabetes in Japan	8
Comment on “Lower glycemic status was associated with pancreatic cancer risk in prediabetes”	8
Diabetes remission in newly diagnosed type 2 diabetes mellitus through short‐term continuous subcutaneous insulin infusion intensive therapy combined with low‐carbohydrate diet treatment	7
	7
Pancreatic beta‐cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes	7
Risk factors for persistent decline in eGFR of Japanese patients with diabetes: Analysis using a large‐scale diabetes registry J‐	7
Gastrointestinal symptoms in patients receiving imeglimin in combination with metformin: A post‐hoc analysis of imeglimin clinical trial data	7
Polar vasculosis is associated with better kidney outcome in type 2 diabetes with biopsy‐proven diabetic kidney disease: A multicenter cohort study	7
Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real‐world data from pharmacies in Japan	7
Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea‐treated KCNJ11 neonatal diabetes	7
Endothelial Activation Stress Index predicts all‐cause and cardiovascular mortality in patients with diabetes: A nationwide study	7
Calebin A mitigates oxidative stress and inflammation in diabetic nephropathy via Nrf2/ HO ‐1 and NF	7
Methodological and statistical considerations on calebin A‐mediated nephroprotection in diabetic nephropathy	7
Elucidation of the clinical traits of diabetic chorea through a questionnaire survey of people with diabetic chorea from 59 Japanese hospitals	7
Cognitive protection of incretin‐based therapies in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis based on clinical studies	7
miR‐31 ameliorates type 2 diabetic vascular damage through up‐regulation of hypoxia‐inducible factor‐1α/vascular endothelial growth factor‐A	7
The PKM2 activator TEPP‐46 suppresses cellular senescence in hydrogen peroxide‐induced proximal tubular cells and kidney fibrosis in CD‐1db/db	7
Glycated hemoglobin variability and the risk of cardiovascular events in patients with prediabetes and type 2 diabetes mellitus: A post‐hoc analysis of a prospective and multicen	7
Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual‐like protein 1 and acyl‐coenzyme A synthetase l	7
Clinical features and sulfonylurea usage among outpatients with diabetes aged ≥90 years in an urban diabetes clinic in Tokyo	7
Reply to the comments of Saleh et al. on “Coexistence of high visceral fat area and sarcopenia and atherosclerotic markers in old‐old patients with diabetes: Is there an association?”	7
Longitudinal trends in dementia prevalence among individuals with type 2 diabetes in Taiwan (2009–2022)	7
Value of machine learning algorithms for predicting diabetes risk: A subset analysis from a real‐world retrospective cohort study	7
Impact of COVID ‐19 restrictions and their relaxation on body composition and glycemic control in individuals with glucose intolerance in Japan: A si	7
Risk of biliary diseases in patients with type 2 diabetes or obesity treated with tirzepatide: A meta‐analysis	7
Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators	7
The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis	7
Modification effect of receipt of diabetes care on the association between COVID‐19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide	7
Letter to the editor in response to “Glycemic control is worse in rural compared to urban type 2 diabetes in Bangladesh, irrespective of food security status”	7
Letter to the Editor in response to the article “Dysregulation of miR ‐21‐5p in diabetic nephropathy and its role in inflammatory response”	7
β‐Cell dysfunction in diabetes: The role of neuroplastin	6
Issue Information	6
Issue Information	6
Clinical and psychological effects of the JADEC Diabetes Card System assessed using the Problem Areas in Diabetes ( PAID	6
Decreased serum musclin concentration is independently associated with the high prevalence of sarcopenia in Chinese middle‐elderly patients with type 2 diabetes mellitus	6
Association between diabetic peripheral neuropathy and lower limb muscle strength in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis	6
Gaps in the management of diabetes in Asia: A need for improved awareness and strategies in men's sexual health	6
Issue Information	6
Targeting the miR ‐224‐5p/ PTEN pathway: A previously under‐characterized strategy to attenuate me	6
Induction of proximal tubular proliferation and lengthening in response to sodium glucose linked cotransporter‐2 inhibition in experimental rats	6
Association of low‐grade albuminuria and triple‐line pattern as markers of early peripheral vascular remodeling in adolescents with type 1 diabetes	6
Methodological considerations in interpreting RDW ‐ CV as a biomarker for renal tubular injury in	6
Issue Information	6
Issue Information	6
Eating behaviors and incidence of type 2 diabetes in Japanese people: The population‐based Panasonic cohort study 15	6
Expression profile of circular RNAs in type 2 diabetes mellitus patients with retinopathy	6
Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia	6
Effect of intensive lifestyle intervention on the association between weight variability and major adverse cardiovascular events in overweight or obese adults with type 2 diabetes mellitus	6
Body composition and risk of gestational diabetes mellitus: A univariable and multivariable Mendelian randomization study	6
Association between early‐stage diabetic nephropathy and the delayed monophasic glucose peak during oral glucose tolerance test in type 2 diabetes mellitus	6
Interaction effect between low birthweight and resistin gene rs1862513 variant on insulin resistance and type 2 diabetes mellitus in adulthood: Toon Genome Study	6
Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes	6
Biomedical outcomes and cardiovascular risks in Chinese adults with type 2 diabetes in the metabolic management center program: A longitudinal comparative study	6
Red cell distribution width ( RDW ), RDW to albumin ratio ( RAR	6
Pontine lesion in hyperglycemic crises: Relevance to osmotic demyelination syndrome and posterior reversible encephalopathy syndrome	6
Issue Information	6
Issue Information	6
Evaluation of inadvertent stigmatization of individuals with diabetes by healthcare professionals	6
Commentary on “Liver function effects of SGLT2 inhibitor and GLP ‐1 receptor agonist combination t	6
Association between serum uric acid‐to‐high‐density lipoprotein cholesterol ratio and insulin resistance in an American population: A population‐based analysis	6
The relationship between depressive symptoms and glycemic control is stronger in women with type 2 diabetes in South Asians: Results from a cross‐sectional multicenter study	6
PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan	6
Role of β‐cell autophagy in β‐cell physiology and the development of diabetes	6
Effect of sodium–glucose cotransporter 2 inhibitors on serum low‐density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus	6
Effects of switching from MiniMed™ 640G to 770G on continuous glucose monitoring metrics and DTR‐QOL scores: An observational study of Japanese p	6
Commentary on “Effectiveness of tele‐guidance for physiotherapy in older patients with type 2 diabetes: A randomized controlled trial”	6
Relationship between elevated circulating thrombospondin‐1 levels and vascular complications in diabetes mellitus	6
Issue Information	5
The cholesterol‐HDL‐glucose (CHG) index and traditional adiposity markers in predicting diabetic retinopathy and nephropathy	5
Issue Information	5
Causal effects of lifestyle and socioeconomic factors on diabetes and its complications and comorbidities: A Mendelian randomization study	5
Application of the integrated data platform combined with dietary management for adults with diabetes: A prospective randomized controlled trial	5
Response to: Methodological concerns on the predictive performance evaluation of anthropometric indices	5
	5
Predictive values of metabolic score for insulin resistance on risk of major adverse cardiovascular events and comparison with other insulin resistance indices among Chinese with and without diabetes	5
Issue Information	5
The roles of output clock genes in regulating glucose metabolism	5
Association between mean platelet volume and kidney events in patients with type 2 diabetes mellitus	5
Clinical signs of type 1 diabetes are associated with type 2 diabetes marker transcription factor 7‐like 2 polymorphism	5
Weight loss improves inflammation by T helper 17 cells in an obese patient with psoriasis at high risk for cardiovascular events	5
Glycemic control and renal function decline in patients with chronic coronary syndrome: A multicenter cohort study	5
Effect of intermittent fasting 16:8 and 14:10 compared with control‐group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial	5
Year‐long effects of COVID‐19 restrictions on glycemic control and body composition in patients with glucose intolerance in Japan: A single‐center retrospective study	5
Searching for LADA in patients with Hashimoto's thyroiditis: A tool for the prevention of LADA	5
Long non‐coding ribonucleic acid zinc finger E‐box binding homeobox 1 antisense RNA 1 regulates myocardial fibrosis in diabetes through the Hippo–Yes‐associated protein signaling pathway	5
A decade of SGLT2 inhibitors: Lessons learned and the road ahead in type 2 diabetes	5
Heart rate variability indices for predicting cardiorenal outcomes: A lesson from the PERL and ACCORD cohorts	5
Elevated small dense low‐density lipoprotein cholesterol to high‐density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction associated fatty liver disease in C	5
Issue Information	5
A case of maturity‐onset diabetes of the young with a pathogenic HNF1A variant and a coexisting NEUROD1 va	5
Machine learning‐based prediction model for adverse pregnancy outcomes in women with gestational diabetes mellitus	5
Impact of coexisting diabetes on survival and risk of developing second primary cancer in diabetes patients receiving drug therapy: A multicenter retrospective cohort study of patients with cancer in	5